Content about Learning

April 25, 2013
Actavis to launch generic ADHD drug in December 2014

Actavis can launch a generic version of an attention deficit hyperactivity disorder drug made by Shire next year under an agreement between the two companies announced Thursday.

April 2, 2013
Reports: Analysis finds steep rise in ADHD diagnoses among children

More than one-tenth of school-age children and nearly one-fifth of high school boys in the United States have received a diagnosis for attention deficit hyperactivity disorder, according to published reports.

January 23, 2013
Industry challenges egregious disease-state related claims made by Internet purveyor of supplements

The National Advertising Division on Tuesday recommended that Nature’s Answer discontinue a wide range of Internet advertising claims for “Bio-Strath,” including claims that the supplement benefits children with ADD/ADHD, pregnant women, people recovering from cancer treatments, people with dementia and people with diabetes.

January 14, 2013
Pfizer announces availability of new ADHD drug

A new drug for treating attention deficit hyperactivity disorder made by Pfizer is now available, the drug maker said.

January 11, 2013
Beiersdorf kicks off consumer awareness, fundraising effort to support mentoring

Skin care company Beiersdorf has announced a consumer awareness and fundraising initiative to support National Mentoring Month.

October 22, 2012
Pfizer buying ADHD drug maker

Pfizer is buying the maker of an attention deficit hyperactivity disorder drug for almost $700 million, Pfizer said Monday.

October 17, 2012
Kmart introduces Latina Smart internship program

Kmart is looking for five interns for a new program designed to provide opportunities to Hispanic women.

September 14, 2012
Impax, Teva settle with J&J, Alza over generic ADHD drug

Two generic drug makers have settled with a subsidiary of Johnson & Johnson and another company concerning a drug used to treat attention deficit hyperactivity disorder.

September 12, 2012
Shire seeks new approval for ADHD drug

Drug maker Shire is seeking Food and Drug Administration approval for a new usage for a drug used to treat attention deficit hyperactivity disorder, the company said Wednesday.

June 16, 2011
PepsiCo donates $50K to National Association of Hispanic Journalists

PepsiCo has donated $50,000 to the National Association of Hispanic Journalists that will be used for scholarships and internships to support Latino students pursuing careers in communications, journalism and social media.

© 2013 Drug Store News. All Rights Reserved.